At 12 months, among patients with T2DM, 42.3 % in the OSA with CPAP group, 30 % in the OSA without CPAP group and 26.1 % in the non-OSA group were on insulin (p=0.448). This evidence concerns the gene INS and obstructive sleep apnea syndrome.